受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2005 Batch: A200509
Pembrolizumab is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities. MW : 146.286 KD.
CAS No. | 1374853-91-4 |
---|---|
Formulation | PBS buffer, pH 7.2 |
Isotype | Human IgG4 |
Source | CHO cells |
Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
Shipping | Shipped under low temperature conditions |
Purity | 99% |
Protein concentration | 12.378mg/ml |
Endotoxin Level | <1EU/mg |
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial [ Nat Med, 2024, 10.1038/s41591-024-02824-y] | PubMed: 38374347 |
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer [ Cancer Cell, 2024, 42(12):2045-2063.e10] | PubMed: 39658541 |
The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation [ Cell Mol Immunol, 2024, 21(1):60-79] | PubMed: 38062129 |
Multi-omic profiling reveals the endogenous and neoplastic responses to immunotherapies in cutaneous T cell lymphoma [ Cell Rep Med, 2024, S2666-3791(24)00196-4] | PubMed: 38670099 |
Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic state [ Cell Rep Med, 2024, 5(12):101869] | PubMed: 39657666 |
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation [ J Immunother Cancer, 2024, 12(5)e008669] | PubMed: 38702145 |
Deprivation of methionine inhibits osteosarcoma growth and metastasis via C1orf112-mediated regulation of mitochondrial functions [ Cell Death Dis, 2024, 15(5):349] | PubMed: 38769167 |
VentX promotes tumor specific immunity and efficacy of immune checkpoint inhibitors [ iScience, 2024, 27(1):108731] | PubMed: 38299030 |
DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer [ Cancer Immunol Immunother, 2024, 73(10):208] | PubMed: 39110249 |
ALK5/VEGFR2 dual inhibitor TU2218 alone or in combination with immune checkpoint inhibitors enhances immune-mediated antitumor effects [ Cancer Immunol Immunother, 2024, 73(10):190] | PubMed: 39105882 |
人間や獣医の診断であるか治療的な使用のためにでない。